| |
| |
| Exchange: |
American Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
57,080,000 |
| Market
Cap: |
174.09(M) |
| Last
Volume: |
97,895 |
Avg
Vol: |
97,627 |
| 52
Week Range: |
$1.32 - $4.2 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drugs - Generic |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : 5.4 |
| Insider 6 Months : 6.1 |
| Insider 3/6 Months : 11.5 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Galectin Therapeutics is a clinical stage biopharmaceutical company engaged in drug research and development to create therapies for fibrotic disease, cancer and selected other diseases. Co.'s main galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis and in clinical studies to decrease portal hypertension and prevent its complication: the development of esophageal varices. GR-MD-02 has the potential to treat various diseases due to galectin-3's involvement in multiple main biological pathways such as fibrosis, immune cell function and immunity, cell differentiation, cell growth, and apoptosis (cell death).
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
4,500 |
5,000 |
6,598 |
28,898 |
| Total Buy Value |
$14,360 |
$15,253 |
$18,107 |
$54,541 |
| Total People Bought |
3 |
4 |
4 |
5 |
| Total Buy Transactions |
3 |
4 |
5 |
11 |
| Total Shares Sold |
25,000 |
25,000 |
25,000 |
45,000 |
| Total Sell Value |
$76,500 |
$76,500 |
$76,500 |
$118,240 |
| Total People Sold |
1 |
1 |
1 |
2 |
| Total Sell Transactions |
2 |
2 |
2 |
4 |
| End Date |
2024-02-25 |
2023-11-24 |
2023-05-26 |
2022-05-26 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Pressler Herman Paul |
Director |
– • – |
2015-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
1,784 |
11,284 |
|
- |
|
| Mauldin John F |
Director |
– • – |
2015-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
11,112 |
17,186 |
|
- |
|
| Greenberg Arthur |
Director |
– • – |
2015-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
11,112 |
107,779 |
|
- |
|
| Prelack Steven |
Director |
– • – |
2015-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
11,112 |
14,048 |
|
- |
|
| Freeman Kevin D |
Director |
– • – |
2015-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
11,112 |
17,112 |
|
- |
|
| Martin Rod D |
Director |
– • – |
2015-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
1,784 |
176,606 |
|
- |
|
| Omenn Gilbert S |
Director |
– • – |
2015-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
11,112 |
40,121 |
|
- |
|
| Czirr James C |
Executive Chairman |
• • – |
2015-01-31 |
4 |
D |
$3.22 |
$300,001 |
D/D |
(93,168) |
883,630 |
|
- |
|
| Czirr James C |
Executive Chairman |
• • – |
2015-01-31 |
4 |
OE |
$1.80 |
$300,001 |
D/D |
166,667 |
976,798 |
|
- |
|
| Amelio Gilbert F |
Director |
– • – |
2014-12-15 |
4 |
S |
$3.69 |
$406 |
D/D |
(110) |
91,974 |
|
- |
|
| Prelack Steven |
Director |
– • – |
2014-11-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(84,283) |
2,936 |
|
- |
|
| Omenn Gilbert S |
Director |
– • – |
2014-09-23 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
29,009 |
|
- |
|
| Omenn Gilbert S |
Director |
– • – |
2014-09-23 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
25,009 |
|
- |
|
| Greenberg Arthur |
Director |
– • – |
2014-08-19 |
4 |
B |
$4.56 |
$4,560 |
D/D |
1,000 |
96,667 |
2.31 |
- |
|
| Freeman Kevin D |
Director |
– • – |
2014-08-15 |
4 |
B |
$4.70 |
$4,700 |
D/D |
1,000 |
3,917 |
2.31 |
- |
|
| Traber Peter G |
President and CEO |
• • – |
2014-08-14 |
4 |
B |
$4.44 |
$17,838 |
D/D |
4,000 |
101,333 |
2.81 |
- |
|
| Callicutt Jack W |
Chief Financial Officer |
• – – |
2014-08-14 |
4 |
B |
$4.55 |
$4,545 |
D/D |
1,000 |
1,260 |
2.66 |
- |
|
| Traber Peter G |
President and CEO |
• • – |
2014-08-13 |
4 |
B |
$4.42 |
$4,416 |
D/D |
1,000 |
97,333 |
2.73 |
- |
|
| Martin Rod D |
Director |
– • – |
2014-05-13 |
4 |
OE |
$1.80 |
$150,001 |
D/D |
83,334 |
174,822 |
|
- |
|
319 Records found
|
|
Page 13 of 13 |
|
|
